Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
86 /100
CRITICAL RISK
Score updated Aug 28, 2026

TVRD — Tvardi Therapeutics, Inc. Dilution Risk Tracker

Track TVRD dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track TVRD — Get alerts when the score changes →

As of August 28, 2026, Tvardi Therapeutics, Inc. (TVRD) has a DilutionWatch DilutionScore of 86/100, rated CRITICAL dilution risk. Tvardi Therapeutics, Inc. has a market capitalization of $31.71M, 13.34M shares outstanding, 1 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
72
💰 Cash Runway
85
📊 Float Risk
60
⚠️ Warrant Exposure
40
🔄 Convertible Debt
85

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 43%
🔁 Convertible Conversion model 60%
• Major convertible overhang: 95% potential dilution
• Convertible risk score very high (85/100)
💰 Capital Raise model 35%
• Low cash runway: 3 months remaining
🔄 Reverse Split model est. 15%
• Only 3 months cash — financial pressure
🔔 Track TVRD — Get forecast alerts →

Market Data

Market Cap$31.71M
Shares Outstanding13.34M
Float6.46M
Cash$20.89M
Debt$174.0K
Short InterestN/A

Institutional Holdings

QoQ: ↓ 98.6% shares (2026Q1 vs prior)
1 institutional holders · 2 shares
#1 DANSKE BANK A/S 2 shares

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest262.5K
Days to Cover1.0
% of Float4.1%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2025-12-31
424B3 ATM 2026-03-06
4 INSIDER TRANSACTION 2026-02-02
4 INSIDER TRANSACTION 2026-02-02
4 INSIDER TRANSACTION 2026-02-02
Full SEC filing analysis available with free account

Recent News

No recent news

Factual TVRD Dilution Snapshot

Tvardi Therapeutics, Inc. (TVRD) has a DilutionScore of 86/100, rated Critical dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track TVRD Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking TVRD — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — CRITICAL Risk

Other CRITICAL dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for TVRD
TVRD FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.